Skip to main content
EnFr

Contraception: DMPA-SC supplement

This special DMPA-SC supplement of the journal Contraception includes 13 articles authored by several organizations on topics including task-sharing, contraceptive continuation, cost and cost-effectiveness, acceptability and feasibility, storage and disposal, and private sector provision across six countries.

Institutional author(s): World Health Organization (WHO), PATH, FHI 360, Tulane School of Public Health and Tropical Medicine, University of Washington, Institut de Recherche en Sciences et de la Santé, College of Medicine, University of Malawi, Institut Supérieur de Statistiques, Makerere University, Institut Africain de Santé Publique (IASP), University of California San Francisco, École de Santé Publique de Lubumbashi, Population Council
Publication date: 2018

Categories

  • Journal article Contraception journal supplement home page
    EN
  • Journal article DMPA-SC: an emerging option to increase women's contraceptive choices
    EN
  • Journal article Family planning provision in pharmacies and drug shops: an urgent prescription
    EN
  • Journal article Continuation of injectable contraception when self-injected vs. administered by a facility-based health worker: a nonrandomized, prospective cohort study in Uganda
    EN
  • Journal article Costs of administering injectable contraceptives through health workers and self-injection: evidence from Burkina Faso, Uganda, and Senegal
    EN
  • Journal article Is contraceptive self-injection cost-effective compared to contraceptive injections from facility-based health workers? Evidence from Uganda
    EN
  • Journal article Client and provider experiences with self-administration of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) in Malawi
    EN
  • Journal article An observational study to test the acceptability and feasibility of using medical and nursing students to instruct clients in DMPA-SC self-injection at the community level in Kinshasa
    EN
  • Journal article Women's satisfaction, use, storage and disposal of subcutaneous depot medroxyprogesterone acetate (DMPA-SC) during a randomized trial
    EN
  • Journal article Continuation of subcutaneous or intramuscular injectable contraception when administered by facility-based and community health workers: findings from a prospective cohort study in Burkina Faso and Uganda
    EN
  • Predictors of DMPA-SC continuation among urban Nigerian women: the influence of counseling quality and side effects
    EN
  • Journal article Introducing the subcutaneous depot medroxyprogesterone acetate injectable contraceptive via social marketing: lessons learned from Nigeria's private sector
    EN
  • Journal article Task-shifting the provision of DMPA-SC in the DR Congo: Perspectives from two different groups of providers
    EN
  • Journal article Acceptability of the distribution of DMPA-SC by community health workers among acceptors in the rural province of Lualaba in the Democratic Republic of the Congo: a pilot study
    EN
  • Journal article Feasibility of patent and proprietary medicine vendor provision of injectable contraceptives: preliminary results from implementation science research in Oyo and Nasarawa, Nigeria
    EN